Sanofi SA Nirsevimab R&D Investor Event Transcript - Thomson StreetEvents

Sanofi SA Nirsevimab R&D Investor Event Transcript

Sanofi SA Nirsevimab R&D Investor Event Transcript - Thomson StreetEvents
Sanofi SA Nirsevimab R&D Investor Event Transcript
Published Jul 30, 2020
20 pages (13356 words) — Published Jul 30, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SASY.PA conference call or presentation 30-Jul-20 3:00pm GMT

  
Brief Excerpt:

...Good afternoon, and good evening to Asia. I'm Eva Schaefer-Jansen of Sanofi Investor Relations. Welcome to this event. This is the fifth in a series of 5 R&D events, highlighting the accelerating pipeline momentum building within Sanofi R&D. Today, we will focus on the Phase IIb results of nirsevimab just published in the New England Journal of Medicine. As usual, you can find the slides to this call on the Investors page of our website at sanofi.com. Next slide, please. So I would like to remind you that information presented during this event contain forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our Document d'Enregistrement Universel for a description of these factors. Next slide, please. So I would like to introduce you to our speakers today. We have here Thomas Triomphe, Global Head of Sanofi Pasteur; we have Su-Peing...

  
Report Type:

Transcript

Source:
Company:
Sanofi SA
Ticker
SASY.PA
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Sanofi SA Q3 2020 Earnings Call Transcript – 2020-10-29 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 29-Oct-20 1:30pm GMT

Sanofi SA at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript – 2020-09-23 – US$ 54.00 – Edited Transcript of SASY.PA presentation 23-Sep-20 2:30pm GMT

Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript – 2020-09-17 – US$ 54.00 – Edited Transcript of SASY.PA presentation 17-Sep-20 12:20pm GMT

Sanofi SA at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-15 – US$ 54.00 – Edited Transcript of SASY.PA presentation 15-Sep-20 6:45pm GMT

Sanofi SA To Acquire Principia Biopharma Inc - M&A Call Transcript – 2020-08-17 – US$ 54.00 – Edited Transcript of SASY.PA M&A conference call or presentation 17-Aug-20 1:00pm GMT

Sanofi SA Q2 2020 Earnings Call Transcript – 2020-07-29 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 29-Jul-20 12:30pm GMT

Sanofi SA Q2 2017 Earnings Call Summary – 2017-07-31 – US$ 54.00 – Edited Brief of SASY.PA earnings conference call or presentation 31-Jul-17 12:30pm GMT

Sanofi SA Q2 2017 Earnings Call Transcript – 2017-07-31 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 31-Jul-17 12:30pm GMT

Sanofi SA at Leerink Swann Global Healthcare Conference Transcript – 2013-02-14 – US$ 54.00 – Edited Transcript of SASY.PA presentation 14-Feb-13 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Sanofi SA Nirsevimab R&D Investor Event Transcript" Jul 30, 2020. Alacra Store. May 23, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Sanofi-SA-Nirsevimab-R-D-Investor-Event-T13267763>
  
APA:
Thomson StreetEvents. (2020). Sanofi SA Nirsevimab R&D Investor Event Transcript Jul 30, 2020. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Sanofi-SA-Nirsevimab-R-D-Investor-Event-T13267763>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.